Product Description
| Brand |
Snibe |
| Sample Type |
Serum/ Urine |
| Pack Size |
100T |
| CAT No. |
130204001M |
| Application |
Renal Marker |
The kit has been designed for the quantitative determination of I22- microglobulin (I22-MG) in human serum or urine. The method can be used for samples over the range of 0.03-10I14g/ml. The test has to be performed on the Fully-auto chemiluminescence immunoassay (CLIA) analyzer MAGLUMI (Including Maglumi 600,Maglumi 1000,Maglumi 1000 Plus, Maglumi 2000,Maglumi 2000 Plus,Maglumi 3000 and Maglumi 4000).
High Sensitivity and Specificity for Reliable ResultsThe MAGLUMI beta2-MG (CLIA) kit delivers outstanding sensitivity and accuracy for detecting Beta 2-microglobulin in clinical samples. This ensures precise quantification, supporting clinicians in making informed diagnostic decisions. The utilization of advanced chemiluminescence technology minimizes potential errors and maximizes efficiency.
Seamless Integration and Efficient WorkflowSpecifically engineered for use with MAGLUMI series chemiluminescence analyzers, this reagent kit allows both automatic and manual sample loading. This flexibility, coupled with a high-throughput capability, boosts laboratory productivity and optimizes turnaround time for patient results.
Comprehensive and Convenient Kit DesignSnibe's kit includes magnetic microbeads, calibrators, controls, buffers, and a chemiluminescent substrate-minimizing the need for additional reagents and preparation steps. Its ready-to-use format streamlines workflow, while clear calibration protocols maintain consistency and reliability for each lot.
FAQ's of Snibe MAGLUMI beta2-MG (CLIA):
Q: How is the MAGLUMI beta2-MG (CLIA) kit used in clinical laboratories?
A: The kit is designed for use on Snibe MAGLUMI chemiluminescence analyzers to quantitatively detect Beta 2-microglobulin in serum or plasma samples. Laboratories simply load the ready-to-use reagents and follow standard operating procedures for automatic or manual analysis.
Q: What is the intended benefit of using this kit for beta2-MG testing?
A: The main benefits are high sensitivity, specificity, and streamlined workflow, all of which contribute to accurate diagnosis and monitoring of diseases where beta2-MG is a key biomarker. The kit supports efficient, high-throughput operation, aiding prompt clinical decision-making.
Q: When should calibration be performed for this kit?
A: Calibration is generally required once for every new kit lot, or according to the analyzer manufacturer's recommendations. This ensures consistent result accuracy throughout the kit's usage.
Q: What sample types can be tested with this kit, and how much sample is needed?
A: The kit is validated for use with human serum or plasma. Sample volume requirements follow the instrument's standard assay protocol, typically necessitating only minimal amounts due to the assay's high sensitivity.
Q: Where should the kit be stored to maintain its shelf life and performance?
A: Store all components at 2-8C, protected from light, as specified in the kit's instructions. Proper storage preserves reagent integrity for up to 12 months from the manufacturing date.
Q: What is the measurement range and detection limit of the kit?
A: The kit provides accurate quantification of beta2-MG within the range of 1.0 to 20.0 mg/L, with a detection limit of 1.0 mg/L, meeting clinical diagnostic standards.
Q: Which analyzers are compatible with this reagent kit?
A: The MAGLUMI beta2-MG (CLIA) reagent kit is intended exclusively for use with Snibe MAGLUMI series chemiluminescence analyzers, ensuring optimal performance and reliability.